Ann: September 2023 Quarterly Update and Appendix 4C, page-11

Agree, all shares are a gamble, and companies, Biotech ones especially where they can, try to diversify their products from the original product with the most potential, to try to leverage off that product with side lines and "variations on the theme" to spread the risk both for themselves and for investors. It's now looking like a heads or tails toss of the coin with PTX-100 on one side of the coin and a blank on the other side, all depending on the results of the next batch of data released.

Re the comment about how much does SYC get paid, it matters not, as long as he can deliver a result, people would never ask that question, if he doesn't I don't think it is relevant still as it won't change the result, well paid or not well paid, it will not alter the efficacy of PTX-100, in addition to this, 'Not Held' is definitely important when reading posts, not always but often, what is the incentive to post??? Remember Kerry Packer said always back self-interest, that way you always know someone will try their best!